GlassScriptPhysician profile
Diane Friedman
NPI 1306233382
$2,148.85
in general payments reported to CMS, 2019-2025
17 companies · $264 in 2025
The $264 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $744 · 2022: $722 · 2023: $293 · 2024: $126 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $684.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $683.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $464.04 | 2021-2022 | |
| Abbvie INC. | $439.44 | 2021-2023 | |
| Alkermes, INC. | $226.21 | 2024-2025 | Lybalvi |
| Biohaven Pharmaceutical Holding Company LTD. | $209.46 | 2022 | |
| Axsome Therapeutics, INC. | $150.77 | 2023-2025 | Auvelity |
| Biohaven Pharmaceuticals, INC. | $139.21 | 2021 | |
| Merz Pharmaceuticals, LLC | $115.83 | 2021-2023 | Xeomin |
| Allergan, INC. | $62.85 | 2021 | |
| Upsher-Smith Laboratories LLC | $50.79 | 2021 | |
| Lilly USA, LLC | $50.56 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $45.74 | 2023 | Qelbree |
| Arbor Pharmaceuticals, INC. | $43.95 | 2021 | |
| Boston Scientific Corporation | $41.47 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Teva Pharmaceuticals USA, INC. | $36.50 | 2021-2022 | |
| Pfizer INC. | $29.15 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Currax Pharmaceuticals LLC | $27.14 | 2022-2023 | Onzetra Xsail |
| Collegium Pharmaceutical, INC. | $15.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diane Friedman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.